SCHEMBL3094209

SCHEMBL3094209

SCCCOc1cc(-c2ccc(Cl)c(Cl)c2)ccc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 5/20 0.48
CYP1B1 Q16678 1/20 0.42
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
HTR2C P28335 1/20 0.39
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
IDO1 P14902 1/20 0.37
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3323664 0.87 AHR (0.42) AHRCYP1B1ALDH1A1LMNAHTR2C
SCHEMBL3322865 0.82 PPARD (0.39) KMT2A
SCHEMBL3322824 0.73 HTR2A (0.43) ALDH1A1LMNAMEN1USP2POLB
SCHEMBL29769221 0.69 AHR (1.00) AHRCYP1B1ALDH1A1MEN1USP2
SCHEMBL137915 0.69 AHR (1.00) AHRCYP1B1ALDH1A1MEN1USP2
SCHEMBL3111469 0.69 AHR (0.44) AHRCYP1B1ALDH1A1MEN1USP2
SCHEMBL31336824 0.68 PPARG (0.35) MEN1MAPTMAPK1KMT2ANPSR1
SCHEMBL4451807 0.67 RAB9A (0.51) ALDH1A1LMNAMAPTCYP2C9FFAR4
SCHEMBL22701009 0.66 HDAC3 (0.39)
SCHEMBL22964307 0.64 ALDH1A1 (0.47) ALDH1A1LMNAMEN1USP2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100120784-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-05-13 US disclosed
EP-2148878-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Ltd. (CA) 2010-02-03 EP disclosed
WO-2008128335-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2008-10-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120784-A1 NOVEL HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, ACSL6 AHR 205/4885CYP1B1 736/4885ALDH1A1 2012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.